巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Brainstorm Cell Therapeutics

    BCLI
    4.180
    0.010
    0.24%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Brainstorm Cell Therapeutics - 延遲價格・最後更新於 29/09 12:00
    最高位
    4.190
    最低位
    4.070
    開市價
    --
    前收市價
    4.170
    成交量(千)
    8.02
    成交額(百萬)
    0.30
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    152.51
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    4.700 - 2.520
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Brainstorm Cell Therapeutics
    證券代碼
    BCLI.US
    所屬板塊
    Biotechnology
    公司業務
    Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
    發行量
    36277953
    公司總部
    1325 Avenue of Americas, 28th Floor
    公司網址
    https://www.brainstorm-cell.com
    公司電郵
    pshah@brainstorm-cell.com
    公司電話
    +1 201 488-0460
    暫無內容

    關於

    Brainstorm Cell Therapeutics(BCLI.US)所屬的行業板塊為Biotechnology。
    Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
    詳細公司背景可參考: https://www.brainstorm-cell.com